Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05361304 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
123
Enrollment target
6
Study locations

NCT05361304 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 123 participants, roughly in line with the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target. The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05361304, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
6
Study locations

Study Summary

This study is a feasibility, multi-site, randomized, double-masked, 2-arm parallel group design, 2-week dispensing study with weekly visits to evaluate visual acuity.

Conditions Studied

Interventions

  • DEVICE senofilcon A contact lenses made with a novel manufacturing technology
  • DEVICE senofilcon A contact lenses made with the current manufacturing technology

Study Locations (6)

Florida

  • VRC - Jacksonville
  • Flora Chen Poveda OD, PA - Orange Park - Orange Park
  • Tallahassee Eye Center - Tallahassee

New York

  • Sacco Eye Group - Vestal

Utah

  • William J. Bogus, O.D. - Salt Lake City

Virginia

  • Botetourt Eyecare, LLC - Salem

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2022-05-16
Est. Completion 2022-07-05
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT05361304

The ClinicalTrials.gov registry entry for NCT05361304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A contact lenses made with a novel manufacturing technology is the first listed.

NCT05361304 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, New York, Utah.

Frequently Asked Questions

What is clinical trial NCT05361304 about?

NCT05361304 is a clinical study titled "Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.". This study is a feasibility, multi-site, randomized, double-masked, 2-arm parallel group design, 2-week dispensing study with weekly visits to evaluate visual acuity.

What is the current status of trial NCT05361304?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-05-16. Estimated completion is 2022-07-05.

What conditions does trial NCT05361304 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT05361304?

The interventions under investigation include: senofilcon A contact lenses made with a novel manufacturing technology (DEVICE), senofilcon A contact lenses made with the current manufacturing technology (DEVICE).

Who is sponsoring clinical trial NCT05361304?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05361304 being conducted?

This trial has 6 study locations across Florida, New York, Utah, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.